Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) Stock Price

ZYBTStock

$1.89−72.06%52W

Market Cap$89.57M

P/E28.23x

PEG Ratio—

Div yield—

Beta-0.64

ZYBT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)90.28%

Price vs S&P 500 (4W)43.56%

VGM Score46.00

P/E Ratio (Annual)28.23x

P/CF (Annual)28.01x

Book Value / Share (Quarterly)$0.81

P/TBV (Annual)1.88x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)664.65%

Cash Flow / Share (Quarterly)$0.00

Payout Ratio (TTM)78.85%

Price vs S&P 500 (YTD)57.61%

Gross Margin (TTM)24.21%

Net Profit Margin (TTM)-51.18%

EPS (TTM)$-0.29

10-Day Avg Trading Volume0.33M

EPS Excl Extra (TTM)$-0.29

EPS (Annual)$-0.22

Dividend / Share (Annual)$0.00

ROI (Annual)-21.51%

Gross Margin (Annual)20.51%

Net Profit Margin (5Y Avg)6557.38%

Cash / Share (Quarterly)$0.17

Revenue Growth QoQ (YoY)-37.56%

P/E Normalized (Annual)28.23x

ROA (Last FY)-15.99%

Revenue Growth TTM (YoY)-4.17%

EBITD / Share (TTM)$-0.23

ROE (5Y Avg)4.14%

Operating Margin (TTM)-55.62%

Cash Flow / Share (Annual)$0.00

P/B Ratio1.50x

P/B Ratio (Quarterly)1.47x

Net Income / Employee (Annual)$-37,390

Net Interest Coverage (TTM)-19.60x

ROA (TTM)-19.44%

EPS Incl Extra (Annual)$-0.22

Current Ratio (Annual)1.14x

Quick Ratio (Quarterly)0.80x

3-Month Avg Trading Volume3.69M

52-Week Price Return-72.06%

EV / Free Cash Flow (Annual)565.91x

Revenue / Employee (TTM)$95,755

Tangible BV / Share (Quarterly)$0.63

P/S Ratio (Annual)3.21x

Asset Turnover (Annual)0.27x

52-Week High$1.94

Operating Margin (5Y Avg)9304.42%

EPS Excl Extra (Annual)$-0.22

26-Week Price Return101.53%

Quick Ratio (Annual)0.80x

13-Week Price Return124.86%

Total Debt / Equity (Annual)0.30x

Current Ratio (Quarterly)1.14x

Enterprise Value$59.05M

Asset Turnover (TTM)0.38x

Revenue / Employee (Annual)$62,357

Inventory Turnover (Annual)1.90x

Pretax Margin (Annual)-61.77%

Cash / Share (Annual)$0.17

3-Month Return Std Dev2080.90%

Gross Margin (5Y Avg)22493.12%

Net Income / Employee (TTM)$-49,013

ROE (Last FY)-27.93%

Net Interest Coverage (Annual)-16.12x

EPS Basic Excl Extra (Annual)$-0.22

P/FCF (TTM)24.36x

Receivables Turnover (TTM)3.45x

EV / Free Cash Flow (TTM)565.91x

Total Debt / Equity (Quarterly)0.30x

EPS Incl Extra (TTM)$-0.29

Receivables Turnover (Annual)2.25x

ROI (TTM)-25.79%

P/S Ratio (TTM)2.09x

Pretax Margin (5Y Avg)9040.83%

Revenue / Share (Annual)$0.36

Tangible BV / Share (Annual)$0.63

Price vs S&P 500 (52W)-90.37%

Year-to-Date Return69.57%

5-Day Price Return27.45%

EPS Normalized (Annual)$-0.22

ROA (5Y Avg)2.40%

Net Profit Margin (Annual)-59.97%

Month-to-Date Return46.62%

EBITD / Share (Annual)$-0.14

EPS Growth (3Y)528.02%

Operating Margin (Annual)-60.59%

LT Debt / Equity (Annual)0.04x

P/CF (TTM)28.01x

ROI (5Y Avg)3.75%

LT Debt / Equity (Quarterly)0.04x

EPS Basic Excl Extra (TTM)$-0.29

P/TBV (Quarterly)1.88x

Payout Ratio (Annual)141.66%

P/B Ratio (Annual)1.47x

Dividend / Share (TTM)$0.00

Inventory Turnover (TTM)2.78x

Pretax Margin (TTM)-57.51%

Book Value / Share (Annual)$0.81

Price vs S&P 500 (13W)122.07%

Dividend Yield (TTM)0.00%

Beta-0.64x

P/FCF (Annual)531.32x

Revenue / Share (TTM)$0.56

ROE (TTM)-33.33%

52-Week Low$0.09

vGradeC

gGradeD

mGradeB

vgmGradeC

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
ZYBTZhengye Biotechnology Holding Limited Class A Ordinary Shares	C	D	B	$1.89
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Zhengye Biotechnology Holding Limited Class A Ordinary Shares

Zhengye Biotechnology manufactures and distributes veterinary vaccines primarily for livestock, with swine and poultry vaccines generating the majority of revenue. The company offers a diverse product range including vaccines for cattle, goats, sheep, waterfowl, and pets, sold across Chinese provinces and exported to Vietnam, Pakistan, and Egypt.